Know Cancer

or
forgot password

Serum Free Light Chain Ratio, Total Kappa/Lambda Ratio, and Immunofixation as Prognostic Factors in Multiple Myeloma.


N/A
18 Years
75 Years
Not Enrolling
Both
Multiple Myeloma

Thank you

Trial Information

Serum Free Light Chain Ratio, Total Kappa/Lambda Ratio, and Immunofixation as Prognostic Factors in Multiple Myeloma.


Inclusion Criteria:



- Patients affected with Multiple Myeloma who underwent autologous or auto/allogenic
stem cell transplantation.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Retrospective

Authority:

Italy: Ministry of Health

Study ID:

sFLC r, KLR and IFIX

NCT ID:

NCT00910078

Start Date:

Completion Date:

Related Keywords:

  • Multiple Myeloma
  • Total kappa and lambda ratio
  • Stem cell transplantation
  • Serum immunofixation
  • Multiple Myeloma
  • Neoplasms, Plasma Cell

Name

Location